Combined blockade of IL6 and PD-1/PD-L1 signals increases the expression of T cell-attracting chemokines and facilitates IFN-γ-producing CD4 T cell infiltration into tumor tissues, producing a synergistic anti-tumor effect (Tsukamoto et al., 2018). Here, PDCD1 is linked to neoplasm.